Your browser doesn't support javascript.
loading
Assessing Kidney Transplantation Using ECMO-Supported Donors Within a KDPI-Based Allocation System.
Altshuler, Peter J; Pace, Devon J; Preston, William A; Vincent, Sage A; Shah, Ashesh P; Glorioso, Jaime M; Maley, Warren R; Frank, Adam M; Ramirez, Carlo B; West, Sharon; Hasz, Richard; Bodzin, Adam S.
Afiliação
  • Altshuler PJ; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
  • Pace DJ; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
  • Preston WA; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
  • Vincent SA; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
  • Shah AP; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
  • Glorioso JM; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
  • Maley WR; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
  • Frank AM; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
  • Ramirez CB; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
  • West S; Gift of Life Donor Program, Philadelphia, PA.
  • Hasz R; Gift of Life Donor Program, Philadelphia, PA.
  • Bodzin AS; Department of Surgery, Thomas Jefferson University, Philadelphia, PA.
Transplant Direct ; 9(11): e1521, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37829245
ABSTRACT

Background:

Organ donors supported by extracorporeal membrane oxygenation (ECMO) have historically been considered high-risk and are judiciously utilized. This study examines transplant outcomes using renal allografts from donors supported on ECMO for nondonation purposes.

Methods:

Retrospective review of the Gift of Life (Pennsylvania, New Jersey, Delaware) organ procurement organization database, cross-referenced to the Organ Procurement and Transplantation Network database, assessed kidney transplants using donors supported on venoarterial (VA) and venovenous (VV) ECMO for nondonation purposes. Transplants using VA- and VV-ECMO donors were compared with Kidney Donor Profile Index (KDPI)-stratified non-ECMO donors. Regression modeling of the entire ECMO and non-ECMO populations assessed ECMO as predictive of graft survival. Additional regression of the ECMO population alone assessed for donor features associated with graft survival.

Results:

Seventy-eight ECMO donors yielded 128 kidney transplants (VA 80, VV 48). Comparing outcomes using these donors to kidney transplants using organs from KDPI-stratified non-ECMO donors, VA- and VV-ECMO donor grafts conferred similar rates of delayed graft function and posttransplant renal function to KDPI-matched non-ECMO counterparts. VA-ECMO kidneys demonstrated superior graft survival compared with the lowest-quality (KDPI 86%-100%) non-ECMO kidneys and similar graft survival to KDPI <85% non-ECMO kidneys. VV-ECMO showed inferior graft survival to all but the lowest-quality (KDPI 86%-100%) non-ECMO kidneys. VV-ECMO, but not VA-ECMO, was associated with increased risk of graft loss on multivariable regression (hazard ratios-VA 1.02, VV 2.18). Higher KDPI, advanced age, increased body mass index, hypertension, and diabetes were identified as high-risk features of ECMO donors.

Conclusions:

Kidney transplantation using appropriately selected ECMO donors can safely expand the donor pool. Ongoing studies are necessary to determine best practice patterns using kidneys from these donors.

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Transplant Direct Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Panamá

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Transplant Direct Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Panamá